Stemtech Corp (STEK)
Sector: Wholesale-Drugs, Proprietaries & Druggists' Sundries
Industry: Drug Manufacturers - Specialty & Generic
Stemtech Corporation
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,500,012 |
| Nov 16, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1,576,286 |
| Nov 13, 2026 | 0.0001 | 0.0001 | 0.0000 | 0.0000 | 36,963 |
| Nov 12, 2026 | 0.0001 | 0.0001 | 0.0000 | 0.0000 | 1,877,470 |
| Nov 11, 2026 | 0.0000 | 0.0001 | 0.0000 | 0.0000 | 27,000 |
| Nov 10, 2026 | 0.0001 | 0.0002 | 0.0000 | 0.0001 | 1,520,280 |
| Nov 9, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 100,000 |
| Nov 6, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 4,701,630 |
| Nov 5, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 26,165,017 |
| Nov 4, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 81,455,493 |
| Nov 3, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 304,564 |
| Nov 2, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,293,800 |
| Oct 30, 2026 | 0.0000 | 0.0001 | 0.0000 | 0.0001 | 164,705 |
| Oct 29, 2026 | 0.0001 | 0.0001 | 0.0000 | 0.0001 | 1,313,047 |
| Oct 28, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 162,900 |
| Oct 27, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 8,630,000 |
| Oct 26, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 5,071,306 |
| Oct 23, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 111,927,321 |
| Oct 22, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 249,000 |
| Oct 20, 2026 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 2,000,000 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Sale | 1.00M | $30.0K | Jun 23, 2025 |
| Name | Shares | % | Source |
|---|---|---|---|
KAPLAN BENJAMIN NATHANIEL Director | 831.0K | 0.0% | FORM 4 |
Insiders
- KAPLAN BENJAMIN NATHANIELDirector
Stemtech Corporation is a pioneering company specializing in stem cell nutrition.
It formulates scientifically-backed products designed to optimize the body's intrinsic stem cell physiology. With a market presence spanning the Americas, Latin America, and Asia, its offerings are engineered to bolster the natural functions of the body's stem cells. These solutions achieve this by stimulating the release of more stem cells, facilitating their efficient circulation through the bloodstream, and guiding their migration into various tissues. This process enables the stem cells to perform their continuous regenerative and repair tasks, crucial for maintaining optimal health and vitality.
The company's comprehensive portfolio of dietary supplements includes prominent brands such as RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze. Stemtech Corporation's operations are headquartered in Miramar, Florida.
No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.
30d Avg
11.97M
60d Avg
8.49M
90d Avg
7.53M
Signal8's dilution snapshot of STEK as of Sep 30, 2026 records 1 outstanding warrant series, from SEC filings. Stemtech Corp (OTC: STEK) traded at $0.0001 on Nov 17, 2026. 52-week range: $0.0000 to $0.0028. The company is in the Healthcare sector (Drug Manufacturers - Specialty & Generic).